Please use this identifier to cite or link to this item: http://hdl.handle.net/10603/257636
Full metadata record
DC FieldValueLanguage
dc.coverage.spatialPharmacy
dc.date.accessioned2019-09-16T09:53:15Z-
dc.date.available2019-09-16T09:53:15Z-
dc.identifier.urihttp://hdl.handle.net/10603/257636-
dc.description.abstractavailable
dc.format.extent1-111 p
dc.languageEnglish
dc.relation137
dc.rightsuniversity
dc.titleComparative haemovigilance requirements of brics countries with that of usfda and ema guidelines
dc.title.alternative
dc.creator.researcherSreekumar, P K
dc.subject.keywordClinical Pre Clinical and Health,Pharmacology and Toxicology,Pharmacology and Pharmacy
dc.subject.keywordHaemovigilance,BRICS,USFDA,EMA
dc.description.notequotsummary p 95-98, References p 99-106quot
dc.contributor.guidePramod Kumar, T M
dc.publisher.placeMysore
dc.publisher.universityJSS Academy of Higher Education and Research
dc.publisher.institutionColleges of Pharmacy
dc.date.registered2015
dc.date.completed2018
dc.date.awarded22-08-2019
dc.format.dimensions3
dc.format.accompanyingmaterialCD
dc.source.universityUniversity
dc.type.degreePh.D.
Appears in Departments:College of Pharmacy

Files in This Item:
File Description SizeFormat 
01_title.pdfAttached File254.87 kBAdobe PDFView/Open
02_certificates.pdf900.73 kBAdobe PDFView/Open
03_acknowledgement.pdf73.25 kBAdobe PDFView/Open
04_contents.pdf85.11 kBAdobe PDFView/Open
05_preface.pdf4.44 kBAdobe PDFView/Open
06_list of tables and figures.pdf146.29 kBAdobe PDFView/Open
07_abstract.pdf222.7 kBAdobe PDFView/Open
08_chapter 1.pdf265.76 kBAdobe PDFView/Open
09_chapter 2.pdf437.7 kBAdobe PDFView/Open
10_chapter 3.pdf1.01 MBAdobe PDFView/Open
11_chapter 4.pdf600.62 kBAdobe PDFView/Open
12_chapter 5.pdf270.27 kBAdobe PDFView/Open
13_references.pdf248.97 kBAdobe PDFView/Open
14_appendix.pdf174.93 kBAdobe PDFView/Open


Items in Shodhganga are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetric Badge: